✦ LIBER ✦

Radiation exposure to family members of patients with thyrotoxicosis treated with iodine-131

✍ Scribed by Tone Cappelen; Jan Frede Unhjem; Anne Lise Amundsen; Gunnhild Kravdal; Ivar Følling

Publisher: Springer
Year: 2005
Tongue: English
Weight: 123 KB
Volume: 33
Category: Article
ISSN: 0340-6997
DOI: 10.1007/s00259-005-1888-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Radiation exposure of the families of ou

Radiation exposure of the families of outpatients treated with radioiodine (iodine-131) for hyperthyroidism

✍ Sally F. Barrington; Michael J. O’Doherty; Andrew G. Kettle; William H. Thomson; 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 58 KB

Real-life radiation burden to relatives

Real-life radiation burden to relatives of patients treated with iodine-131: a study in eight centres in Flanders (Belgium)

✍ Myriam Monsieurs; Hubert Thierens; Rudi A Dierckx; Kristien Casier; Elisabeth De 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 107 KB

Measurement of the internal dose to fami

Measurement of the internal dose to families of outpatients treated with131I for hyperthyroidism

✍ S. F. Barrington; P. Anderson; A. G. Kettle; R. Gadd; W. H. Thomson; S. Batchelo 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 165 KB

Is it safe to treat hyperthyroid patient

Is it safe to treat hyperthyroid patients with I-131 without fear of thyroid storm?

✍ Vani Vuayakumar; M. L. Nusynowitz; S. Ali 📂 Article 📅 2006 🏛 Springer Japan 🌐 English ⚖ 284 KB

Prevalence of antibodies to hepatitis C

Prevalence of antibodies to hepatitis C virus among family members of patients with chronic hepatitis C

✍ N. Napoli; G. Fiore; F. Vella; G. Fera; O. Schiraldi 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 371 KB

The efficacy of galantamine in the treat

The efficacy of galantamine in the treatment of Alzheimer's disease: comparison of patients previously treated with acetylcholinesterase inhibitors to patients with no prior exposure

✍ J. E. Mintzer; P. Kershaw 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB 👁 2 views

## Abstract ## Background Acetylcholinesterase inhibitors (AChEIs) can provide benefits at the cognitive, behavioral, and functional levels to patients with Alzheimer's disease (AD). With more AChEIs now available, treatment considerations may include whether the patient has had prior exposure to